Paper Details

  1. Home
  2. Paper Details

Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.

Author: BahraMarcus, BergThomas, KahlAndreas, KiesslingAnja, NeuhausPeter, NeuhausRuth, NeumannUlf, PuhlGero, SchmitzVolker

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Peginterferon-alfa2b was safe and effective in achieving SVR in HCV recurrence after combined kidney and liver transplantation.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Several studies have demonstrated safety and efficacy of treatment protocols using pegylated interferon alfa-2b (PegIntron) and ribavirin in hepatitis C (HCV) recurrence and liver transplantation but no data exists about antiviral treatment following combined liver and kidney transplanta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/18290566

データ提供：米国国立医学図書館（NLM）

Peginterferon alfa-2b: A Potential Treatment for Hepatitis C Recurrence

Hepatitis C is a viral infection that can cause serious liver damage. This study examines the effectiveness of peginterferon alfa-2b and ribavirin in treating hepatitis C recurrence following combined liver and kidney transplantation. The authors found that this antiviral treatment was safe and effective in a small group of patients.

Combating Hepatitis C: Finding Oasis in the Desert of Infection

The study demonstrates that peginterferon alfa-2b, combined with ribavirin, can be a viable treatment option for hepatitis C recurrence after combined liver and kidney transplantation. While more research is needed, this study offers a glimmer of hope for patients facing this challenging condition. It's like discovering a hidden oasis in the vast desert of liver disease, providing a much-needed source of hydration and hope.

A New Path to Liver Health: A Journey of Hope

This research highlights the potential for effective treatments in managing hepatitis C recurrence, even in complex situations like combined liver and kidney transplantation. It's like finding a new route through the desert, a path that leads to better treatment options and a brighter future for those facing this challenging condition.

Dr.Camel's Conclusion

This study provides valuable insights into the treatment of hepatitis C recurrence after combined liver and kidney transplantation. It's a reminder that even in the face of complex medical challenges, there is hope for effective treatments and a chance for recovery. This research is like finding a new spring of water in the desert of liver disease, offering a path to renewed health and well-being.

Date :
  1. Date Completed 2008-05-07
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

18290566

DOI: Digital Object Identifier

18290566

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.